Preoperative oral ondansetron for pediatric tonsillectomy

Anesthesia and Analgesia

Volumn 82, Issue 3, 1996, Pages 558-562

  Rose, John B ^a,b   Randall Brenn, B ^a,b   Corddry, David H ^a,b   Thomas, Phyllis C ^a,b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CODEINE; DEXAMETHASONE; FENTANYL; GLYCOPYRRONIUM BROMIDE; ISOFLURANE; MIDAZOLAM; MORPHINE; NALOXONE; NEOSTIGMINE; ONDANSETRON; PARACETAMOL; PLACEBO; THIOPENTAL; VECURONIUM;

ANESTHESIA COMPLICATION; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; PREMEDICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TONSILLECTOMY; VOMITING;

ADMINISTRATION, ORAL; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; ISOFLURANE; MALE; MIDAZOLAM; ONDANSETRON; POSTOPERATIVE COMPLICATIONS; PREANESTHETIC MEDICATION; PREMEDICATION; PROSPECTIVE STUDIES; TONSILLECTOMY; VOMITING;

EID: 9044246673     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199603000-00023     Document Type: Article

References (23)

1. Furst SR, Rodarte A. Prophylactic antiemetic treatment with ondansetron in children undergoing tonsillectomy. Anesthesiology 1994;81:799-803.
2. Litman RS, Wu CL, Catanzaro FA. Ondansetron decreases emesis after tonsillectomy in children. Anesth Analg 1994;78:478-81.
3. Watcha MF, Bras PJ, Cieslak GD, Pennant JH. The dose-response relationship of ondansetron in preventing postoperative emesis in pediatric patients undergoing ambulatory surgery. Anesthesiology 1995;82:47-52.
4. Garden PA, Mitchell SL, Waters KD, et al. Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia. J Clin Oncol 1990;8:1531-5.
5. Pinkerton CR, Williams D, Wootton G, et al. 5-HT3 antagonist ondansetron - an effective outpatient antiemetic in cancer treatment. Arch Dis Child 1990;65:822-5.
6. McQueen KD, Milton JD. Multicenter postmarketing surveillance of ondansetron therapy in pediatric patients. Ann Pharmacother 1994;28:85-92.
7. Williams CL, Sanders PL, Laizure SC, et al. Stability of ondansetron hydrochloride in syrups compounded from tablets. Am J Hosp Pharm 1994;51:806-9.
8. Cohen J, ed. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Erbaum, 1988:56.
9. Splinter WM, Baxter MRN, Gould HM, et al. Oral ondansetron decreases vomiting after tonsillectomy in children. Can J Anaesth 1995;42:277-80.
10. Kenny GNC, Gates JDL, Leeser J, et al. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. Br J Anaesth 1992;68:466-70.
11. Rust M, Cohen LA. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. Anaesthesia 1994;49(Suppl):16-23.
12. Splinter WM, MacNeill HB, Menard EA, et al. Midazolam reduces vomiting after tonsillectomy in children. Can J Anaesth 1995;42:201-3.
13. Rose JB, Martin TM, Corddry DH, et al. Ondansetron reduces the incidence and severity of poststrabismus repair vomiting in children. Anesth Analg 1994;79:486-9.
14. Catlin FI, Grimes WJ. The effect of steroid therapy on recovery from tonsillectomy in children. Arch Otolaryngol Head Neck Surg 1991;117:649-52.
15. Mackenzie R, Tantisira B, Karambelkar DJ, et al. Comparison of ondansetron with ondansetron plus dexamethasone in the prevention of postoperative nausea and vomiting. Anesth Analg 1994;79:961-4.
16. Smith DB, Newlands ES, Rustin GJ, et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991;338:487-90.
17. Roila F, Tonato M, Cognetti F, et al. Prevention of cisplatin-induced emesis: a double blind multicenter randomized cross-over study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991;9:675-8,
18. McEvoy GK, ed. AHFS drug information 95. Bethesda, MD: American Society of Health-System Pharmacists, 1995:2016.
19. Colthrup PV, Palmer JL. The determination in plasma and pharmacokinetics of ondansetron. Eur J Cancer Clin Oncol 1989;25(Suppl 1):S71-4.
20. Hsyu PH, Pritchard JF, Bozigian HP, et al. Oral ondansetron pharmacokinetics: the effect of chemotherapy. J Clin Pharmacol 1994;34:767-73.
21. Hsyu PH, Pritchard JF, Bozigian HP, et al. Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Pharm Res 1994;11:156-9.
22. Blackwell CP, Harding SM. The clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 1989;25(Suppl 1):S21-4.
23. Blake JC, Palmer JL, Minton N, et al. The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment. Br J Clin Pharmacol 1993;35:441-3.